Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace 

Slides:



Advertisements
Similar presentations
Janssen is proud to feature artwork created by people affected by the illnesses and diseases we are committed to treating and preventing. Key Sustainability.
Advertisements

Vision, Mission & Values
AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations.
What is Strategy? (Part Two). Key Concepts Managerial Cognition Business Model Stakeholders The Balanced Scorecard.
Dr. Bhaskar Chatterjee 11th January, 2013, Mumbai.
2 James Crawford Midwest Regional Recruiter-Brad Leighty- District Manager-Alta Division.
Abbott Vascular Eileen Cronin Turning Science into Caring
Pharmaceutical Industry and Boehringer Ingelheim Paul Fonteyne Executive Vice President Head of Marketing & Sales, Prescription Medicines Pharmaceutical.
What Constitutes a Good Quality Annual Report Corporate Social Responsibility Reporting By Ng Kean Kok.
BUSINESS & HUMAN RIGHTS UniCredit on its sustainability path: understanding and managing the financial sector’s responsibilities in terms of human rights”
1. 2 “Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson.”
Corporate Social Responsibility - A new way to communicate with stakeholders? Philip Dewhurst Director of Corporate Affairs, BNFL 10 February 2004.
Citizenship Internal Stakeholder Engagement at Abbott China.
Corporate Responsibility and Third Party Relationships GSK and Contract Manufacturers James Hagan Vice President Corporate Environment, Health & Safety.
The Business Research Company Healthcare. Typical Healthcare Projects Copyright TBRC Business Research. All Rights Reserved. 2 Market Analysis Product.
Abcd Value through Innovation ABCD. Abcd Value Through Innovation Boehringer Ingelheim is committed to becoming the most innovative research, development.
Managing Medical R&D Defining and Realizing Clinical and Commercial Value David J. Wierz Senior Director Commercial Investment & Pricing Strategy Wyeth-Ayerst.
Integrated Biomedical Information for Better Health Workprogramme Call 4 IST Conference- Networking Session.
ABB and Corporate Social Responsibility Dr. Gülden Türktan.
Welcome to Roche. 2 The Roche Group: short overview Roche Diagnostics India Trainee Roche Diagnostics India Our people’s development and careers.
Answers. play video here The Work That Has Chosen Us.
Corporate Social Responsibility
EuroRec/Efpia/CDIR - Brussles March 10-11, Workshop on Towards integration of clinical care & clinical research for better health & high quality.
PUTTING THE PATIENT AT THE CENTER OF HEALTHCARE RESEARCH Towards a more inclusive model.
Responsible Care® Basic Awareness 1. DISCUSSION POINTS 2 WHAT IS RESPONSIBLE CARE®? HOW DOES RESPONSIBLE CARE® ADD VALUE? WHAT CAN YOU DO TO SUPPORT RESPONSIBLE.
Schneider Electric 1 - Division - Name – Date Buildings Business 2011 Corporate Presentation Speaker name Date.
IYF’s experience leveraging partnerships for youth development WB Y2Y Conference Session 4: Leveraging Partnerships: The Role of Various Stakeholders October.
Responsible Care® Awareness for Managers 1. DISCUSSION POINTS 2 WHAT IS RESPONSIBLE CARE®? FEATURES OF RESPONSIBLE CARE® HOW DOES RESPONSIBLE CARE® ADD.
Working with Non-Governmental Agencies: Our African Experience Dr Jack Watters Vice President External Medical Affairs, International Pfizer (EMAI)
Financial aspects of healthcare …..about financial processes, developments etc. in health care organizations in the Netherlands. Remarks to:
MLI51C100 – SESSION #4 MAY 12, 2016 DR. MARGARET C. MCKEE Measurement and Reporting of Corporate Social Performance.
MarketsandMarkets Presents Lab Automation Market worth $4.2 Billion By 2017
Targeted Drug Therapeutics An overview of our technologies and their potential 505(b)(2) applications Sino-American Regulatory Consulting Alliance Yongtian.
MarketsandMarkets Presents Customer Relationship.
© UEG Presentation by Towards more coordination in health research: a report on the UEG research symposium 16/11/2012 Michael Manns General Assembly.
Zaranae Honeycutt. The healthcare industry (also called the medical industry or health economy) is an aggregation and integration of sectors within the.
PROMOTING NEW MEASURES for the protection of workers with oncological conditions Seminar Research project co-funded by the European Commission Palazzo.
Vision, Mission, Strategy and Values. 2 Our Vision To be the world’s leading coatings company by consistently delivering high-quality, innovative and.
BioMérieux’s commitment in the fight against HIV Michel Bonnier VP Public Health.
MarketsandMarkets Presents Bioinformatics Market worth $7.5 Billion By 2017
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
GB590 Corporate Social Responsibility Prof. Ray Kalinski By Willette Marchany Rivera December 13, 2010.
Darragh O’Loughlin MPSI IPU Secretary General Irish Pharmaceutical Healthcare Association RDS, Dublin: 26 November 2013.
Molecular Diagnostics Market : Infectious Disease, Technology
Moiz Bakhiet, MD, PhD, Professor and Chairman
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Tracing the origin of wood for sustainable operation
MarketsandMarkets Presents Oncology Information System Market worth $2.6 Billion by
MarketsandMarkets Presents Global Forecast and Opportunities in Oncology Information System Market
MarketsandMarkets Presents U.S. will hold the leadership in the global Oncology Information System Market
MarketsandMarkets Presents Medical oncology segment accounted for the largest share of the global oncology information system market
MarketsandMarkets Presents Global Oncology Information System market is estimated to grow at a CAGR of 8.5% in the forecast period
MarketsandMarkets Presents The Impact of the Different Market Factors on Global Oncology Information System market in Emerging Economies
MarketsandMarkets Presents Global Oncology Information System Market Share Analysis, By Key Players & Competitive Scenario
MarketsandMarkets Presents Metabolic Testing Market worth $ Million html.
MarketsandMarkets Presents Oncology Information System Market: Scope & Application Market by Stakeholders and Geography
MarketsandMarkets Presents Rising Incidence of Lifestyle Diseases and Increasing Healthcare Expenditure will boost Metabolic Testing Market
MarketsandMarkets Presents Oncology Information System Market is Open up for Growth Opportunities & Present Scenario challenges
Finland, a Global Testbed for Personalized Cancer Research?
What Makes a Novel Technology Innovative?
BayerNet: Getting to ONE
European Commission policy on CSR
Global Medical Device Market Report : Trends, Forecast and Competitive Analysis 1.
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Lab on Chips Market Size Growth During Forecast Period.
Bio-Rad Overview and Statement of Interests
Published by :Accurize Market Research Pvt. Ltd. Copyright © 2019 Accurize Market Research Global Microfluidic Devices.
How Is Precision Medicine Transforming The Health Care Industry?
Global Next Generation Sequencing (NGS) Market (By Products - Consumables, Platforms, Services, Sequencing Services, Bioinformatics, Technology, Applications, End Users, Regions), Key Company Profiles - Forecast to 2025
Presentation transcript:

Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace 

Roche Corporate Principles Mission Our aim as a leading healthcare company is to create, produce and market innovative solutions of high quality for unmet medical needs. Our products and services help to prevent, diagnose and treat diseases, thus enhancing people’s health and quality of life. We do this in a responsible and ethical manner and with a commitment to sustainable development respecting the needs of the individual, the society and the environment. 

CNS -1 % Infectious diseases -6 % Virology +3 % Other -5 % Oncology +33 % Dermatology -13 % Transplantation +17 % Anaemia +79 % Metabolic disorders -2% Inflammation/ bone -9 % Cardiovascular +8 % Roche Divisions / Pharmaceuticals Prescription sales 2002 by therapeutic area 

R&D / Diagnostics Leveraging: Competencies and Resources Research Field Professionals Consumers Applied Science Molecular Diagnostics Centralized Diagnostics Near Patient Testing Diabetes Care Industrial Biochemicals Harmonized systems platforms LightCycler Extensions Protein Expression Viral Load Monitoring Blood Screening Menu Extension Single Strip System Integrated Spot Monitoring BG/ Electrolyte Extensions Continuous Monitoring Automated Pancreas Primary Care System Genomics / Proteomics New diagnostic markers PCR Microbiology/Sepsis Integrated Cancer Care Micro / Nano Technologies (microarrays /microfluidics) Informatics 

Roche Key Figures  Sales:29.7 Billion CHF R&D: 4.3 Billion CHF Employees:69,700 Europe 47% North America 26% Asia 16% Latin America 8% Other 3% More Information at

Roche EH&S Key Figures  11th Year of EH&S Public Reporting (Since 1992) 5th Year of Third Party Verification of Report by PWC Eco-Efficiency Indicators (compared to sales) Energy Usage % CO 2 emissions -60.5% VOC emissions -79.6% Chemical Wastes %

WEC CSR Indicator Screen Brings together many Sustainable Development Charters Allows weighting of Indicators based on importance to company and stakeholder Our dilemma - how to rank the importance to our stakeholders 

Key Issues for Financial & NGO Communities Selection of similar indicators Database for comparing results Clear Definitions Third Party Verification 

Corporate Citizenship Measures Should be Well Defined Consistent Audited / Verified 